Coalition for Epidemic Preparedness Innovations logo

Coalition for Epidemic Preparedness Innovations

North America, District of Columbia, United States, Washington

Description

Coalition for Epidemic Preparedness Innovations (CEPI) is a non profit organisation.

Investor Profile

Coalition for Epidemic Preparedness Innovations has backed more than 18 startups, with 5 new investments in the last 12 months alone. The firm has led 17 rounds, about 94% of its total and boasts 12 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Post Ipo Equity, Undisclosed rounds (top funding stages).
  • Majority of deals are located in United States, South Africa, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 5 rounds in the past year.

Stage Focus

  • Grant (67%)
  • Post Ipo Equity (17%)
  • Undisclosed (6%)
  • Post Ipo Debt (6%)
  • Corporate Round (6%)

Country Focus

  • United States (39%)
  • South Africa (6%)
  • United Kingdom (6%)
  • France (6%)
  • Canada (6%)
  • Austria (6%)
  • Israel (6%)
  • Germany (6%)
  • China (6%)
  • Italy (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Clinical Trials
  • Biopharma
  • Life Science
  • Medical Device
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Coalition for Epidemic Preparedness Innovations frequently co-invest with?

Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 1
HE
Europe, Zuid-Holland, The Netherlands, The Hague
Co-Investments: 2

What are some of recent deals done by Coalition for Epidemic Preparedness Innovations?

POP Biotechnologies

Buffalo, New York, United States

POP Biotechnologies LLC is Buffalo NY biotechnology company.

BiotechnologyHealth CareLife ScienceNanotechnology
GrantJul 24, 2025
Amount Raised: $1,500,000
AdaptVac

Hørsholm, Hovedstaden, Denmark

AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.

BiotechnologyHealth CareTherapeutics
GrantJun 19, 2025
Amount Raised: $12,400,000
Gennova Biopharmaceuticals

Pune, Maharashtra, India

Gennova Biopharmaceuticals is a biotechnology company that develops biotherapeutics and provides product development programs.

BiopharmaBiotechnologyPharmaceutical
Corporate RoundMar 31, 2025
Amount Raised: $13,380,000

Fondazione Biotecnopolo di Siena is a private non-profit foundation with registered office and operations to develop applied research.

GrantMar 19, 2025
Amount Raised: $4,500,000
Micron Biomedical

Atlanta, Georgia, United States

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.

BiopharmaBiotechnologyHealth CareWellness
GrantJan 8, 2025
Amount Raised: $3,700,000
Accumulus Synergy

Burlingame, California, United States

We are developing a global information exchange platform to accelerate the availability of safe and effective medicines.

Health CarePharmaceutical
GrantDec 10, 2024
Amount Raised: $19,100,000
Valneva

Saint-herblain, Pays de la Loire, France

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

BiotechnologyHealth CareMedicalTherapeutics
GrantJul 22, 2024
Amount Raised: $41,300,000
Apriori Bio

Boston, Massachusetts, United States

Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.

BiotechnologyClinical TrialsLife ScienceMedical
GrantJul 8, 2024
Amount Raised: $1,100,000
BioNTech

Mainz, Rheinland-Pfalz, Germany

BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.

BiopharmaBiotechnologyLife SciencePharmaceutical
Post Ipo EquityMay 29, 2024
Amount Raised: $145,000,000
aVaxziPen

Abingdon, Oxfordshire, United Kingdom

aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.

BiotechnologyLife Science
UndisclosedJun 6, 2023
Amount Raised: $1,600,000